PATENT CLAIM ANALYSIS

Application Number: 15989532
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "136100"]

Abstract:
Bispecific EGFR/c-Met antibodies and methods of making and using the molecules.

Claim (Index 24):
The method of  claim 23 , wherein the EGFR and/or c-Met expressing tumor is associated with an EGFR activating mutation, an EGFR gene amplification, increased levels of circulating HGF, a c-Met activating mutation, a c-Met gene amplification or a mutant KRAS.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 93.0
- Lexical Diversity: 1.09091
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14283257', '15386195', '14086588', '14086250', '14085340']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.852748834606762
- 35 USC 102 Novelty (BERT): 0.7412263275711692
- Combined Prediction Score: 0.8415965839032028
- Mean Citation Score: 723.874022
- Max Citation Score: 927.17365
- Similarity Product: 826.0613515768171

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test